Wednesday, September 2, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 21, 2026

Radiation Dose Management Market Set for Strategic Growth, New Report Offers Critical Insights and Competitive Advantage | Astute Analytica

View original at finance.yahoo.com
Radiation Dose Management Market Set for Strategic Growth, New Report Offers Critical Insights and Competitive Advantage | Astute Analytica AstuteAnalytica India Pvt…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • CT and MRI scans have increased by an average of 12% annually since 2020

    80% confidence

  • Cardiac CT scans used for coronary artery screenings in Europe have surged by 25% between 2022 and 2024

    80% confidence

  • 68% of U.S. hospitals operate two or more CT scanners

    80% confidence

  • 92% of hospitals accredited by the Joint Commission utilize automated dose tracking systems to adhere to the 2024 update of TJC Standard PC.01.03.01

    80% confidence

  • United States accounts for approximately 75% of North America's radiation dose management market activity

    80% confidence

  • Only 53% of outpatient centers have adopted automated dose tracking technologies

    80% confidence

  • Hospitals dominate the radiation dose management market, capturing approximately 50% of the share

    80% confidence

  • United States and Germany together account for 45% of all AI-related patents in radiation dose management

    80% confidence

  • 78% of U.S. hospitals had deployed AI-powered dose management systems such as Bayer's Radimetrics and GE HealthCare's DoseWatch by 2024, reflecting a 25% increase in adoption since 2022

    80% confidence

  • By 2024, approximately 65% of U.S. hospitals had deployed advanced dose management solutions like Bayer's Radimetrics or GE HealthCare's DoseWatch

    80% confidence

  • The software segment holds a commanding 70% share of the radiation dose management market

    80% confidence

  • Software platforms have helped reduce protocol deviation errors by as much as 52%

    80% confidence

  • 78% of U.S. hospitals have adopted AI-enabled dose monitoring software in response to the Joint Commission's 2024 imaging safety standards

    80% confidence

  • The global radiation dose management market was valued at US$ 764.2 million in 2024 and is projected to hit the market valuation of US$ 2,301.3 million by 2033 at a CAGR of 13.03% during the forecast period 2025–2033

    80% confidence

  • Medic Vision's FDA-cleared AI platform reduces fluoroscopy time during cardiac procedures by up to 30%

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge: Late-August 2026 Funding Wave Spans Fintech, Enterprise Agents, and Robotics
A dense cluster of funding rounds landing on 2026-08-28 — from identity/fraud fintech player Socure ($156M plus its acquisition of Fravity) to enterprise AI agent startups (Instinct, Generalist AI, Owner), model infrastructure (Stability AI, Emerald AI), and autonomous logistics/aerospace (Gatik, Regent Craft) — signals investors are rotating aggressively into AI-native companies with demonstrable ROI, especially in financial risk/compliance and back-office automation. Parallel signals (Multiverse Computing's compression benchmarks cutting inference cost/latency, and Arkestro/CloneOps.ai publishing hard savings and labor-displacement figures) suggest the funding is chasing efficiency and measurable economic impact rather than pure model scale.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,980
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,980 facts checked against source5,267 source documents archived
Query this data → isubstrate.com
Radiation Dose Management Market Set for Strategic Growth, New Report Offers Critical Insights and Competitive Advantage | Astute Analytica — Source | Via News | Via News